Cancer Risk

Georgia Tech Team Claims 100 Percent Accuracy for Metabolomic Ovarian Cancer Test in Initial Trial
A metabolite-based evidence grown by researchers during the Georgia Institute of Technology identified women with ovarian cancer with 100 percent correctness in the not long ago published 94-subject trial.

Cancer Topics: Accuracy, Cancer, cancer test, claims, Georgia, georgia institute of technology, initial, initial trial, Metabolomic, Ovarian, Ovarian Cancer, percent, team, Tech, Test, trial